Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2009, p. 2650-2653, Vol. 53, No. 6
0066-4804/09/$08.00+0 doi:10.1128/AAC.01716-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Laboratory of Molecular Epidemiology for Infectious Agents, Graduate School of Infection Control Sciences & Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan,1 Department of Pediatrics, Asahikawa-Kosei General Hospital, 1-24 Asahikawa City, Hokkaido 078-8211, Japan,2 Department of Pediatrics, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan,3 Laboratory of Infectious Diseases, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan4
Received 25 December 2008/ Returned for modification 15 February 2009/ Accepted 21 March 2009
Streptococcus agalactiae isolates (n = 189) from patients with invasive infections were analyzed for capsular type by PCR, for antimicrobial susceptibility, and for the presence of resistance genes. In contrast to the predominance of capsular type III in children, types Ib and V were most common among adults. All 45 levofloxacin-resistant strains had two amino acid substitutions, Ser81Leu in the gyrA gene and Ser79Phe in the parC gene, and showed similar pulsed-field gel electrophoresis patterns.
Published ahead of print on 30 March 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»